US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Polyrizon Ltd.

14.30

+0.60004.38%

Pre-market: 13.70-0.1800-1.30%09:01 EDT

Volume:19.23K

Turnover:265.91K

Market Cap:14.90M

PE:-20.10

High:14.49

Open:13.71

Low:13.38

Close:13.70

52wk High:2,235.00

52wk Low:2.88

Shares:1.04M

Float Shares:996.80K

Volume Ratio:0.82

T/O Rate:1.93%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.7114

ROE:-12.20%

ROA:-22.25%

PB:0.81

PE(LYR):- -

Loading ...

Overview Company News Filings

BUZZ-Drug developer Polyrizon climbs on deal to buy 51% of air ambulance operator

BRIEF-Polyrizon Intends To Secure Controlling Stake In Profitable Private Jet Operator

Polyrizon Ltd - Signing of Definitive Agreement Expected Within 30 Days of Mou, Subject to Due Diligence

THOMSON REUTERS

Polyrizon Intends to Secure Controlling Stake in Profitable Private Jet Operator

THOMSON REUTERS

Polyrizon to Acquire 51% Stake in Arrow Aviation for $5.8 Million

BUZZ-U.S. STOCKS ON THE MOVE-SpyGlass, Agomab, Piper Sandler, Molina

BUZZ-U.S. STOCKS ON THE MOVE-Microchip, Under Armour, Avery Dennison

BRIEF-Clearmind Medicine Enters Development Agreement For Intranasal Formulation Of Proprietary Nonhallucinogenic Neuroplastogen MEAI

BUZZ-Polyrizon jumps as it teams up with Clearmind for intranasal drug delivery

Clearmind Medicine Enters Into Development Agreement to Advance Intranasal Formulation for Its Proprietary Non-Hallucinogenic Neuroplastogen Meai

THOMSON REUTERS

Polyrizon Partners with Clearmind to Develop Intranasal MEAI Formulation

Polyrizon Signs an Agreement to Develop Intranasal Proprietary Non-Hallucinogenic Neuroplastogen Formulation

THOMSON REUTERS

Polyrizon intends to acquire 51% stake in Arrow Aviation for NIS 18M

Polyrizon to Acquire 51% Stake in Arrow Aviation

Polyrizon Ltd - to Buy 51% Stake in Arrow Aviation for $5.8 Mln

THOMSON REUTERS

Polyrizon initiates key usability study program for NASARIX

Polyrizon Advances Regulatory Path With Initiation of Usability Study Program for Nasarix™ Allergy Blocker

THOMSON REUTERS

Polyrizon announces board authorized exploration of investment opportunities

BRIEF-Polyrizon Ltd To Explore Revenue-Generating Investment Opportunities In High-Growth Sectors

Polyrizon Ltd: Board Has Approved Pursing Selective Investments That Are Expected to Generate Near-Term Revenues

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PLRZ/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PLRZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PLRZ\",,,,,undefined,":{"symbol":"PLRZ","market":"US","secType":"STK","nameCN":"Polyrizon Ltd.","latestPrice":14.3,"timestamp":1774296000000,"preClose":13.7,"halted":0,"volume":19230,"hourTrading":{"tag":"盘前","latestPrice":13.7,"preClose":13.88,"latestTime":"09:01 EDT","volume":1185,"amount":16759.739400000002,"timestamp":1774357273999,"change":-0.18,"changeRate":-0.012968,"amplitude":0.056196},"delay":0,"changeRate":0.04379562043795631,"floatShares":996800,"shares":1041700,"eps":-0.71144193,"marketStatus":"Pre-Mkt","change":0.6,"latestTime":"03-24 09:04:10 EDT","open":13.71,"high":14.49,"low":13.375,"amount":265912.70922,"amplitude":0.081387,"askPrice":14.2,"askSize":1,"bidPrice":13.6,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-0.71144193,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1774359000000},"marketStatusCode":1,"adr":0,"listingDate":1730174400000,"exchange":"NASDAQ","adjPreClose":13.88,"preHourTrading":{"tag":"盘前","latestPrice":13.7,"preClose":13.88,"latestTime":"09:01 EDT","volume":1185,"amount":16759.739400000002,"timestamp":1774357273999,"change":-0.18,"changeRate":-0.012968,"amplitude":0.056196},"postHourTrading":{"tag":"盘后","latestPrice":14.3,"preClose":14.3,"latestTime":"18:35 EDT","volume":95,"amount":1318.43,"timestamp":1774305305804,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8194136693286971},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PLRZ\",,,,,undefined,":{"symbol":"PLRZ","floatShares":996800,"roa":"-22.25%","roe":"-12.20%","lyrEps":0,"volumeRatio":0.8194136693286971,"shares":1041700,"dividePrice":0,"high":14.49,"amplitude":0.081387,"preClose":13.7,"low":13.375,"week52Low":2.88,"pbRate":"0.81","week52High":2235,"institutionHeld":0,"latestPrice":14.3,"eps":-0.71144193,"divideRate":0,"volume":19230,"delay":0,"ttmEps":-0.71144193,"open":13.71,"prevYearClose":8.49,"prevWeekClose":13.7,"prevMonthClose":12.49,"prevQuarterClose":8.49,"fiveDayClose":14.2,"twentyDayClose":13.92,"sixtyDayClose":7.23},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PLRZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-28","symbol":"PLRZ","defaultRemindTime":1764340200000,"type":"split","dateTimestamp":1764306000000,"forFactor":6,"toFactor":1,"ratio":6},{"market":"US","date":"2025-05-27","symbol":"PLRZ","defaultRemindTime":1748352600000,"type":"split","dateTimestamp":1748318400000,"forFactor":250,"toFactor":1,"ratio":250}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PLRZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PLRZ\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PLRZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PLRZ","date":"2026-03-20","current":-20.100024,"percent":0.130058,"low":-29.515607,"twenty":-13.87234,"median":-6.068669,"eighty":-2.429444,"high":-0.011381,"avg":-8.107917,"sd":6.818421,"marketCap":21518271},"quantilePoints":[{"date":"2024-10-31","current":-13.097935,"twenty":-22.948538,"median":-13.097935,"eighty":-12.489816,"marketCap":7858761},{"date":"2024-11-08","current":-3.903419,"twenty":-12.692522,"median":-4.690878,"eighty":-4.316449,"marketCap":3891709},{"date":"2024-11-15","current":-2.661127,"twenty":-9.219549,"median":-4.249136,"eighty":-3.530862,"marketCap":2653144},{"date":"2024-11-22","current":-2.985655,"twenty":-4.737156,"median":-3.736612,"eighty":-3.09924,"marketCap":2976698},{"date":"2024-11-29","current":-3.042447,"twenty":-4.451075,"median":-3.375089,"eighty":-3.037515,"marketCap":3033320},{"date":"2024-12-06","current":-3.212824,"twenty":-4.383762,"median":-3.342636,"eighty":-3.042447,"marketCap":3203186},{"date":"2024-12-13","current":-3.375088,"twenty":-4.191157,"median":-3.358862,"eighty":-3.047315,"marketCap":3364963},{"date":"2024-12-20","current":-7.561496,"twenty":-4.383762,"median":-3.375088,"eighty":-3.07146,"marketCap":7538812},{"date":"2024-12-27","current":-5.744141,"twenty":-5.095085,"median":-3.407542,"eighty":-3.090153,"marketCap":5726909},{"date":"2025-01-03","current":-5.938858,"twenty":-6.101122,"median":-3.569805,"eighty":-3.132991,"marketCap":5921041},{"date":"2025-01-10","current":-4.997727,"twenty":-6.159537,"median":-3.796975,"eighty":-3.146231,"marketCap":4982734},{"date":"2025-01-17","current":-6.142316,"twenty":-6.098128,"median":-3.933764,"eighty":-3.167391,"marketCap":6123889},{"date":"2025-01-24","current":-5.889893,"twenty":-6.192801,"median":-4.333277,"eighty":-3.193353,"marketCap":5872223},{"date":"2025-01-31","current":-5.553327,"twenty":-6.125488,"median":-4.527162,"eighty":-3.214122,"marketCap":5536667},{"date":"2025-02-07","current":-4.552045,"twenty":-6.087615,"median":-4.738105,"eighty":-3.227753,"marketCap":4538389},{"date":"2025-02-14","current":-4.711914,"twenty":-6.064471,"median":-4.705652,"eighty":-3.245278,"marketCap":4697778},{"date":"2025-02-21","current":-4.522596,"twenty":-6.049761,"median":-4.627772,"eighty":-3.258259,"marketCap":4509028},{"date":"2025-02-28","current":-3.707687,"twenty":-6.000655,"median":-4.535397,"eighty":-3.316674,"marketCap":3696564},{"date":"2025-03-07","current":-3.460732,"twenty":-5.929065,"median":-4.501561,"eighty":-3.241954,"marketCap":3450350},{"date":"2025-03-14","current":-1.846098,"twenty":-5.873065,"median":-4.396383,"eighty":-3.213473,"marketCap":2852222},{"date":"2025-03-21","current":-1.508371,"twenty":-5.793429,"median":-4.291207,"eighty":-3.160314,"marketCap":2330433},{"date":"2025-03-28","current":-1.353625,"twenty":-5.705978,"median":-3.977976,"eighty":-3.07146,"marketCap":2091350},{"date":"2025-04-04","current":-0.974631,"twenty":-5.536499,"median":-3.903419,"eighty":-3.030526,"marketCap":1505805},{"date":"2025-04-11","current":-0.980061,"twenty":-5.4398,"median":-3.702849,"eighty":-2.640357,"marketCap":1514194},{"date":"2025-04-17","current":-0.985491,"twenty":-5.322255,"median":-3.619184,"eighty":-1.846098,"marketCap":1522583},{"date":"2025-04-25","current":-0.947483,"twenty":-5.174691,"median":-3.5049,"eighty":-1.520317,"marketCap":1463861},{"date":"2025-05-02","current":-0.687943,"twenty":-5.159991,"median":-3.434137,"eighty":-1.353625,"marketCap":1062872},{"date":"2025-05-09","current":-2.602277,"twenty":-5.095085,"median":-3.375088,"eighty":-1.466019,"marketCap":4020518},{"date":"2025-05-16","current":-0.039201,"twenty":-5.02132,"median":-3.354145,"eighty":-1.299871,"marketCap":60566},{"date":"2025-05-23","current":-0.018499,"twenty":-5.006408,"median":-3.310183,"eighty":-1.057434,"marketCap":28581},{"date":"2025-05-30","current":-0.022023,"twenty":-4.999463,"median":-3.245278,"eighty":-1.021327,"marketCap":34025},{"date":"2025-06-06","current":-0.014912,"twenty":-4.937359,"median":-3.214447,"eighty":-0.978975,"marketCap":23039},{"date":"2025-06-13","current":-0.018851,"twenty":-4.922267,"median":-3.183486,"eighty":-0.945854,"marketCap":29125},{"date":"2025-06-20","current":-0.013358,"twenty":-4.871782,"median":-3.155299,"eighty":-0.895899,"marketCap":20638},{"date":"2025-06-27","current":-2.431375,"twenty":-4.817057,"median":-3.116926,"eighty":-0.895899,"marketCap":3756474},{"date":"2025-07-03","current":-2.428961,"twenty":-4.79003,"median":-3.054617,"eighty":-0.90676,"marketCap":3752744},{"date":"2025-07-11","current":-2.469311,"twenty":-4.75787,"median":-3.036282,"eighty":-0.929565,"marketCap":3815085},{"date":"2025-07-18","current":-3.343916,"twenty":-4.728069,"median":-3.039365,"eighty":-0.942596,"marketCap":5166350},{"date":"2025-07-25","current":-4.793774,"twenty":-4.784488,"median":-3.066787,"eighty":-0.954976,"marketCap":7406381},{"date":"2025-08-01","current":-9.134632,"twenty":-4.922267,"median":-3.137242,"eighty":-0.969039,"marketCap":14113006},{"date":"2025-08-08","current":-8.476938,"twenty":-5.004125,"median":-3.155299,"eighty":-0.973817,"marketCap":13096869},{"date":"2025-08-15","current":-8.18463,"twenty":-5.134029,"median":-3.19779,"eighty":-0.976803,"marketCap":12645253},{"date":"2025-08-22","current":-7.746168,"twenty":-5.410414,"median":-3.21607,"eighty":-0.982233,"marketCap":11967829},{"date":"2025-08-29","current":-7.600014,"twenty":-5.856236,"median":-3.245278,"eighty":-0.987228,"marketCap":11742021},{"date":"2025-09-05","current":-7.819245,"twenty":-6.049761,"median":-3.325781,"eighty":-0.992223,"marketCap":12080733},{"date":"2025-09-12","current":-7.143282,"twenty":-6.209629,"median":-3.343916,"eighty":-1.006667,"marketCap":11036370},{"date":"2025-09-19","current":-10.354516,"twenty":-6.696876,"median":-3.375088,"eighty":-1.026648,"marketCap":11742021},{"date":"2025-09-26","current":-11.070023,"twenty":-7.035762,"median":-3.443585,"eighty":-1.030557,"marketCap":12553406},{"date":"2025-10-03","current":-11.383325,"twenty":-7.364852,"median":-3.487865,"eighty":-1.042883,"marketCap":12908691},{"date":"2025-10-10","current":-13.054272,"twenty":-7.512322,"median":-3.569805,"eighty":-1.058791,"marketCap":14803545},{"date":"2025-10-17","current":-11.174457,"twenty":-7.59231,"median":-3.644879,"eighty":-1.068565,"marketCap":12671834},{"date":"2025-10-24","current":-11.278891,"twenty":-7.731553,"median":-3.707687,"eighty":-1.123948,"marketCap":12790262},{"date":"2025-10-31","current":-10.75672,"twenty":-7.950784,"median":-3.905854,"eighty":-1.280758,"marketCap":12198121},{"date":"2025-11-07","current":-9.567215,"twenty":-8.038476,"median":-3.996712,"eighty":-1.310622,"marketCap":10849222},{"date":"2025-11-14","current":-8.045608,"twenty":-8.360015,"median":-4.312242,"eighty":-1.376104,"marketCap":9123720},{"date":"2025-11-21","current":-6.109399,"twenty":-8.170015,"median":-4.417419,"eighty":-1.474489,"marketCap":6928059},{"date":"2025-11-28","current":-5.587228,"twenty":-8.111553,"median":-4.501561,"eighty":-1.508371,"marketCap":6335917},{"date":"2025-12-05","current":-25.23826,"twenty":-8.403861,"median":-4.535397,"eighty":-1.515701,"marketCap":28620187},{"date":"2025-12-12","current":-21.591766,"twenty":-8.696169,"median":-4.627772,"eighty":-1.520317,"marketCap":24485063},{"date":"2025-12-19","current":-17.597159,"twenty":-9.06593,"median":-4.711914,"eighty":-1.541633,"marketCap":19955178},{"date":"2025-12-26","current":-13.245735,"twenty":-9.27961,"median":-4.754698,"eighty":-1.546299,"marketCap":15020663},{"date":"2026-01-02","current":-14.777436,"twenty":-10.201257,"median":-4.798393,"eighty":-1.579229,"marketCap":16757612},{"date":"2026-01-09","current":-23.341039,"twenty":-10.662157,"median":-4.922267,"eighty":-1.630419,"marketCap":26468738},{"date":"2026-01-16","current":-21.842963,"twenty":-11.038692,"median":-4.999213,"eighty":-1.702674,"marketCap":24769920},{"date":"2026-01-23","current":-22.02569,"twenty":-11.165081,"median":-5.003554,"eighty":-1.780942,"marketCap":24977133},{"date":"2026-01-30","current":-18.441421,"twenty":-11.278891,"median":-5.035187,"eighty":-1.871075,"marketCap":20912571},{"date":"2026-02-06","current":-17.471559,"twenty":-11.383325,"median":-5.167341,"eighty":-1.959036,"marketCap":19812748},{"date":"2026-02-13","current":-19.664289,"twenty":-11.445985,"median":-5.322255,"eighty":-2.161828,"marketCap":22299304},{"date":"2026-02-20","current":-19.158274,"twenty":-11.780175,"median":-5.500199,"eighty":-2.356399,"marketCap":21725483},{"date":"2026-02-27","current":-19.24261,"twenty":-12.048622,"median":-5.587228,"eighty":-2.377712,"marketCap":21821120},{"date":"2026-03-06","current":-19.130163,"twenty":-12.337157,"median":-5.805751,"eighty":-2.404957,"marketCap":21693605},{"date":"2026-03-13","current":-21.491564,"twenty":-13.089202,"median":-5.977481,"eighty":-2.428961,"marketCap":24371434},{"date":"2026-03-20","current":-18.975548,"twenty":-13.87234,"median":-6.068669,"eighty":-2.429444,"marketCap":21518271}],"updateTime":1774340412774},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PLRZ\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610647780","title":"BUZZ-Drug developer Polyrizon climbs on deal to buy 51% of air ambulance operator","url":"https://stock-news.laohu8.com/highlight/detail?id=2610647780","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610647780?lang=en_us&edition=fundamental","pubTime":"2026-02-10 20:35","pubTimestamp":1770726932,"startTime":"0","endTime":"0","summary":"BUZZ-Drug developer Polyrizon climbs on deal to buy 51% of air ambulance operator** Shares of drug developer Polyrizon PLRZ.O rise 10.04% to $14.58 premarket** Co says it signed a nonbinding deal to buy 51% of medical transport services provider Arrow Aviation ** Arrow provides services including air ambulance flights and medical evacuations, using its fleet of private jets** PLRZ says Arrow generated about $19 million in annual unaudited revenue and $3 million in adjusted earnings** Says a third party will transfer a Hawker 800 aircraft valued at $3.5 million to Arrow in exchange for convertible notes of Polyrizon ** Arrow's shareholders will waive the aviation firm's debts in exchange for additional Polyrizon convertible notes – PLRZ** Shares halved in value in 2025  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nL4N3Z61A6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ"],"gpt_icon":0},{"id":"2610642376","title":"BRIEF-Polyrizon Intends To Secure Controlling Stake In Profitable Private Jet Operator","url":"https://stock-news.laohu8.com/highlight/detail?id=2610642376","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610642376?lang=en_us&edition=fundamental","pubTime":"2026-02-10 20:01","pubTimestamp":1770724893,"startTime":"0","endTime":"0","summary":"BRIEF-Polyrizon Intends To Secure Controlling Stake In Profitable Private Jet OperatorFeb 10 (Reuters) - Polyrizon Ltd PLRZ.O:POLYRIZON INTENDS TO SECURE CONTROLLING STAKE IN PROFITABLE PRIVATE JET OP","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nFWN3Z60N9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ"],"gpt_icon":0},{"id":"2610664447","title":"Polyrizon Ltd - Signing of Definitive Agreement Expected Within 30 Days of Mou, Subject to Due Diligence","url":"https://stock-news.laohu8.com/highlight/detail?id=2610664447","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610664447?lang=en_us&edition=fundamental","pubTime":"2026-02-10 19:56","pubTimestamp":1770724609,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nFWN3Z60N9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ"],"gpt_icon":0},{"id":"2610644497","title":"Polyrizon Intends to Secure Controlling Stake in Profitable Private Jet Operator","url":"https://stock-news.laohu8.com/highlight/detail?id=2610644497","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610644497?lang=en_us&edition=fundamental","pubTime":"2026-02-10 19:56","pubTimestamp":1770724609,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nFWN3Z60N9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ"],"gpt_icon":0},{"id":"2610457644","title":"Polyrizon to Acquire 51% Stake in Arrow Aviation for $5.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2610457644","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610457644?lang=en_us&edition=fundamental","pubTime":"2026-02-10 19:55","pubTimestamp":1770724512,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd. has signed a non-binding Memorandum of Understanding with Arrow Aviation Ltd., a global private aviation company, to acquire a 51% stake in Arrow Aviation for approximately $5.8 million . The proposed deal includes ancillary arrangements such as the transfer of a Hawker 800 aircraft, valued at $3.5 million, to Arrow Aviation in exchange for a convertible note issued by Polyrizon. Existing Arrow Aviation shareholders will forgive outstanding shareholder debts in return for additional convertible notes from Polyrizon, allowing Arrow Aviation to be debt-free after the transaction closes. The agreement also outlines mutual options for the remaining 49% of Arrow Aviation’s shares, exercisable after two years based on financial performance metrics, potentially allowing Polyrizon to acquire full ownership. Arrow Aviation reported approximately $19 million in annual unaudited revenues and about $3 million in adjusted EBITDA. Completion of the transaction remains subject to due d","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nNDL3wVxfq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2210149790.SGD","SG9999014005.SGD","LU2095319765.USD","IE00BKPKM429.USD","NDAQ","SG9999014013.SGD","SG9999014021.USD","PLRZ","BK4585","LU0314104364.USD","BK4588","LU2210150020.SGD","IE00B64PRP62.GBP","BK4112","IE00B3QW5Z07.USD","SG9999014039.USD"],"gpt_icon":0},{"id":"2609151275","title":"BUZZ-U.S. STOCKS ON THE MOVE-SpyGlass, Agomab, Piper Sandler, Molina","url":"https://stock-news.laohu8.com/highlight/detail?id=2609151275","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609151275?lang=en_us&edition=fundamental","pubTime":"2026-02-07 02:45","pubTimestamp":1770403531,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-SpyGlass, Agomab, Piper Sandler, Molina Eikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nL6N3Z20MX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDE","AVY","CG","MCHP","NVR","NWSA","AGMB","RIOT","ROIV","NEM","PM","LEN","UAA","TGTX","EQT","MAXN","PHM","THAR","GWW","PIPR","UI","OFRM","VG","NSC","KBH","NWL","PLRZ","PAA","HOYY","HL","EXE","BIIB","AZYY","CNX","FTNT","DOCS","MGM","SGP","COTY","MOH","HUBG"],"gpt_icon":1},{"id":"2609859779","title":"BUZZ-U.S. STOCKS ON THE MOVE-Microchip, Under Armour, Avery Dennison","url":"https://stock-news.laohu8.com/highlight/detail?id=2609859779","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609859779?lang=en_us&edition=fundamental","pubTime":"2026-02-06 23:56","pubTimestamp":1770393385,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Microchip, Under Armour, Avery DennisonEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsle","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nL6N3Z20YC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NWL","PAA","PM","NEM","HOYY","MAXN","CDE","EQT","VG","CG","OFRM","EXE","UAA","09399","HODU","MCHP","3LMI.UK","COTY","GWW","AMZZ","AMZD","FTNT","ROBN","MOH","RIOT","HUBG","07399","DOCS","HL","NSC","09799","AVY","PLRZ","BIIB","ROIV","TGTX","THAR","NWSA","UI","CNX","MGM"],"gpt_icon":1},{"id":"2609962715","title":"BRIEF-Clearmind Medicine Enters Development Agreement For Intranasal Formulation Of Proprietary Nonhallucinogenic Neuroplastogen MEAI","url":"https://stock-news.laohu8.com/highlight/detail?id=2609962715","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609962715?lang=en_us&edition=fundamental","pubTime":"2026-02-06 21:30","pubTimestamp":1770384643,"startTime":"0","endTime":"0","summary":"BRIEF-Clearmind Medicine Enters Development Agreement For Intranasal Formulation Of Proprietary Nonhallucinogenic Neuroplastogen MEAIFeb 6 (Reuters) - Clearmind Medicine Inc CMND.O:CLEARMIND MEDICINE ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nFWN3Z20V9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND","PLRZ"],"gpt_icon":0},{"id":"2609596155","title":"BUZZ-Polyrizon jumps as it teams up with Clearmind for intranasal drug delivery","url":"https://stock-news.laohu8.com/highlight/detail?id=2609596155","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609596155?lang=en_us&edition=fundamental","pubTime":"2026-02-06 21:25","pubTimestamp":1770384335,"startTime":"0","endTime":"0","summary":"BUZZ-Polyrizon jumps as it teams up with Clearmind for intranasal drug delivery** Shares of drug developer Polyrizon PLRZ.O rise 12.6% to $14.00 premarket ** Co says it will develop an intranasal version of Clearmind’s CMND.O experimental MEAI therapy, being studied for addiction-related brain disorders** CNMD's shares were up 20% at $1.7 premarket** CNMD's MEAI is designed to reshape neural pathways without hallucinations; intranasal delivery may help faster absorption and bypass the liver, per co** Co says its gel-like nasal platform aims to keep drugs longer in the nose and improve targeted delivery** PLRZ shares down over 99%, CNMD down ~41% in 2025  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nL4N3Z21E3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ","BK4007","CMND"],"gpt_icon":0},{"id":"2609953545","title":"Clearmind Medicine Enters Into Development Agreement to Advance Intranasal Formulation for Its Proprietary Non-Hallucinogenic Neuroplastogen Meai","url":"https://stock-news.laohu8.com/highlight/detail?id=2609953545","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609953545?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:55","pubTimestamp":1770382530,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nFWN3Z20V9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CMND","PLRZ"],"gpt_icon":0},{"id":"2609259539","title":"Polyrizon Partners with Clearmind to Develop Intranasal MEAI Formulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2609259539","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609259539?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:55","pubTimestamp":1770382510,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd., a pre-clinical-stage biotechnology company, has entered into a development agreement with Clearmind Medicine Inc., a clinical-stage biopharmaceutical firm. The collaboration focuses on developing a proprietary intranasal formulation of MEAI, Clearmind's next-generation, non-hallucinogenic neuroplastogen drug candidate aimed at treating addiction-related and other central nervous system conditions. Polyrizon will leverage its advanced intranasal delivery platform to enhance the clinical development of MEAI, offering targeted delivery and potentially faster absorption. The partnership is expected to support Clearmind's future clinical programs and highlights Polyrizon's expertise in specialized intranasal drug delivery solutions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL95mddZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IE00BKPKM429.USD","LU2095319765.USD","BK4585","SG9999014013.SGD","SG9999014005.SGD","LU2210150020.SGD","SG9999014039.USD","IE00B3QW5Z07.USD","BK4588","BK4112","IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU0314104364.USD","CMND","NDAQ","PLRZ","SG9999014021.USD","LU2210149790.SGD"],"gpt_icon":0},{"id":"2609595351","title":"Polyrizon Signs an Agreement to Develop Intranasal Proprietary Non-Hallucinogenic Neuroplastogen Formulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2609595351","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609595351?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:55","pubTimestamp":1770382500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nTUA32DWG8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMND","PLRZ","BK4007"],"gpt_icon":0},{"id":"2608696793","title":"Polyrizon intends to acquire 51% stake in Arrow Aviation for NIS 18M","url":"https://stock-news.laohu8.com/highlight/detail?id=2608696793","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608696793?lang=en_us&edition=fundamental","pubTime":"2026-02-04 20:15","pubTimestamp":1770207320,"startTime":"0","endTime":"0","summary":"Polyrizon (PLRZ) announced the signing of a non-binding Memorandum of Understanding with Arrow Aviation, a global private aviation company. Under t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/polyrizon-intends-to-acquire-51-stake-in-arrow-aviation-for-nis-18m-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/polyrizon-intends-to-acquire-51-stake-in-arrow-aviation-for-nis-18m-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AROW","PLRZ","BK4211"],"gpt_icon":0},{"id":"2608667233","title":"Polyrizon to Acquire 51% Stake in Arrow Aviation","url":"https://stock-news.laohu8.com/highlight/detail?id=2608667233","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608667233?lang=en_us&edition=fundamental","pubTime":"2026-02-04 20:12","pubTimestamp":1770207135,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd. has signed a non-binding Memorandum of Understanding with Arrow Aviation Ltd., under which Polyrizon intends to acquire a 51% stake in Arrow Aviation for approximately $5.8 million in cash. The deal includes ancillary arrangements such as the transfer of a Hawker 800 aircraft valued at $3.5 million to Arrow Aviation by a third party, in exchange for a convertible note issued by Polyrizon. Additionally, existing Arrow Aviation shareholders will forgive outstanding debts in return for convertible notes from Polyrizon, allowing Arrow Aviation to emerge debt-free after the closing. The agreement outlines mutual call and put options on the remaining 49% of Arrow Aviation shares, exercisable after two years and based on agreed financial metrics, which could result in Polyrizon ultimately acquiring 100% of Arrow Aviation. Arrow Aviation currently reports annual unaudited revenues of approximately $19 million and adjusted EBITDA of about $3 million. The signing of a definitive a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL2CfN7c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","SG9999014013.SGD","LU2210150020.SGD","BK4588","SG9999014005.SGD","LU2210149790.SGD","IE00B64PRP62.GBP","IE00BKPKM429.USD","BK4112","IE00B3QW5Z07.USD","NDAQ","LU0314104364.USD","PLRZ","IE00BGHQF748.EUR","LU2095319765.USD","SG9999014039.USD","SG9999014021.USD"],"gpt_icon":0},{"id":"2608667163","title":"Polyrizon Ltd - to Buy 51% Stake in Arrow Aviation for $5.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2608667163","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608667163?lang=en_us&edition=fundamental","pubTime":"2026-02-04 20:12","pubTimestamp":1770207120,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nTUA8YD90G:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ"],"gpt_icon":0},{"id":"2605974414","title":"Polyrizon initiates key usability study program for NASARIX","url":"https://stock-news.laohu8.com/highlight/detail?id=2605974414","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605974414?lang=en_us&edition=fundamental","pubTime":"2026-01-22 22:31","pubTimestamp":1769092283,"startTime":"0","endTime":"0","summary":"Polyrizon (PLRZ) announced the initiation of a key usability study program for its lead product candidate, NASARIX, an intranasal allergy blocker d...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/polyrizon-initiates-key-usability-study-program-for-nasarix-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/polyrizon-initiates-key-usability-study-program-for-nasarix-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLRZ"],"gpt_icon":0},{"id":"2605492701","title":"Polyrizon Advances Regulatory Path With Initiation of Usability Study Program for Nasarix™ Allergy Blocker","url":"https://stock-news.laohu8.com/highlight/detail?id=2605492701","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605492701?lang=en_us&edition=fundamental","pubTime":"2026-01-22 22:25","pubTimestamp":1769091900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nTUA81KWXR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ"],"gpt_icon":0},{"id":"2603368761","title":"Polyrizon announces board authorized exploration of investment opportunities","url":"https://stock-news.laohu8.com/highlight/detail?id=2603368761","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603368761?lang=en_us&edition=fundamental","pubTime":"2026-01-13 21:55","pubTimestamp":1768312515,"startTime":"0","endTime":"0","summary":"Polyrizon (PLRZ) recently announced that its Board of Directors has authorized the exploration of strategic investment opportunities in select reve...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/polyrizon-announces-board-authorized-exploration-of-investment-opportunities-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/polyrizon-announces-board-authorized-exploration-of-investment-opportunities-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLRZ"],"gpt_icon":0},{"id":"2603682777","title":"BRIEF-Polyrizon Ltd To Explore Revenue-Generating Investment Opportunities In High-Growth Sectors","url":"https://stock-news.laohu8.com/highlight/detail?id=2603682777","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603682777?lang=en_us&edition=fundamental","pubTime":"2026-01-13 21:43","pubTimestamp":1768311783,"startTime":"0","endTime":"0","summary":"BRIEF-Polyrizon Ltd To Explore Revenue-Generating Investment Opportunities In High-Growth SectorsJan 13 (Reuters) - Polyrizon Ltd PLRZ.O:POLYRIZON LTD: TO EXPLORE REVENUE-GENERATING INVESTMENT OPPORTU","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nFWN3YE13D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ"],"gpt_icon":0},{"id":"2603822316","title":"Polyrizon Ltd: Board Has Approved Pursing Selective Investments That Are Expected to Generate Near-Term Revenues","url":"https://stock-news.laohu8.com/highlight/detail?id=2603822316","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603822316?lang=en_us&edition=fundamental","pubTime":"2026-01-13 21:40","pubTimestamp":1768311610,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nFWN3YE13D:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":80,"code":"91000000","status":"200"}]}}